Method for activating the lipid catabolic metabolism in enteric epithelium and improving the lipid metabolism in enteric epithelium
Abstract
Disclosed are a method for activating lipid metabolism in the small intestine epithelium and also a method for promoting accumulation of fatty acids into the small intestine epithelium, each of which features administering an effective amount of a diacylglycerol. Also disclosed are methods for improving various symptoms in diabetes, which have ingesting a diacylglycerol. Ingestion of the diacylglycerol leads to accumulation of the fatty acids in the small intestine. The fatty acids so accumulated promote induction of β-oxidation, thereby not only activating lipid catabolism but also making it difficult to allow lipids to accumulate as triacylglycerols. This series of actions eventually results in development of lowering action for blood remnant-like lipoprotein level and also lowering action for blood leptin level, and hence, lipid metabolism is improved. Further, energy consumption is enhanced by promoting the induction of β-oxidation and activating lipid catabolism.
Claims
exact text as granted — not AI-modified1 - 21 . (canceled)
22 . A method for treating diabetes, which comprises administering an effective amount of a diacylglycerol to a diabetic patient.
23 . The method according to claim 22 , wherein 15 to 90 wt. % of constituent fatty acids of said diacylglycerol comprise ω3 unsaturated fatty acids.
24 . The method according to claim 22 or 23 , wherein 1,3-diacylglycerols in said diacylglycerol amount to at least 50 wt. % of the whole diacylglycerol.
25 - 31 . (canceled)
32 . A method of dietary therapy for a diabetic patient, which comprises administering an effective amount of a diacylglycerol.
33 - 34 . (canceled)Join the waitlist — get patent alerts
Track US2005148666A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.